Prashant Kesharwani

Nov 1, 2024 | molecular-cancer.biomedcentral.com | Saurav Kumar |Prashant Kesharwani |AL Mughram |Salem Dawood Salman |Saurav Jha |Waleed H. Almalki | +3 more

5-Florouracil is often used in cancer therapy as a thymidylate synthase inhibitor. Nonetheless, its efficacy in cancer treatment is limited by poor absorption and off-target side effects [241]. Targeted delivery of 5-FU using carefully designed nano-carriers might increase its therapeutic potential while reducing negative effects [242].

Apr 1, 2024 | pharmafocusasia.com | Prashant Kesharwani

Author(s) : Prashant KesharwaniBook Description:Design and Applications of Microneedles in Drug Delivery and Therapeutics details the design, characterization, and applications of this novel drug delivery system. Microneedles offer several advantages over traditional oral and parenteral approaches due to their ability to be fabricated and altered in shape, size and material type, and their convenience to be matched to specific treatment needs.

Jan 6, 2024 | pharmafocusasia.com | Prashant Kesharwani

Author(s) : Prashant KesharwaniBook Description:Nanomedicine in Cancer Immunotherapy bridges the two disciplines of nanotechnology and immunology, summarizing the latest research into novel cancer treatments, often personalized to the patient. The book covers a wide range of nanomaterial types for use in cancer immunotherapy, including hydrogel, lipid, exosome, gold and peptide nanoparticles.